164 related articles for article (PubMed ID: 34120564)
1. Developmental consequences of children born from mothers with telbivudine treatment during late pregnancy: A prospective study with 3-year follow-up.
Yi W; Cao X; Zeng Z; Cao W; Zhang Y; Sun F; Wang Y; Wan G; Li M; Xie Y
Virulence; 2021 Dec; 12(1):1527-1537. PubMed ID: 34120564
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of telbivudine and tenofovir disoproxil fumarate in preventing hepatitis B vertical transmission: A real-life practice.
Liu J; Wang J; Yan T; Du D; Qi C; Cao F; Yao N; Yang Y; He Y; Tian Z; Ren D; Zhu L; Chen T; Zhao Y
J Viral Hepat; 2019 Oct; 26(10):1170-1177. PubMed ID: 31177596
[TBL] [Abstract][Full Text] [Related]
3. Telbivudine or lamivudine use in late pregnancy safely reduces perinatal transmission of hepatitis B virus in real-life practice.
Zhang H; Pan CQ; Pang Q; Tian R; Yan M; Liu X
Hepatology; 2014 Aug; 60(2):468-76. PubMed ID: 25187919
[TBL] [Abstract][Full Text] [Related]
4. [Long-term efficacy and safety of telbivudine in the treatment of childbearing patients with chronic hepatitis B].
Zhou Y; Zheng J; Pan H; Lu C
Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):573-6. PubMed ID: 25243955
[TBL] [Abstract][Full Text] [Related]
5. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
[TBL] [Abstract][Full Text] [Related]
6. Motor development delay in offspring is associated with prenatal telbivudine exposure.
Zhou C; Yu Y; Yang Q; Wang H; Hou M; Jin L; Zhang F; Sheng J; Miao M; Yang X; Huang HF
Medicine (Baltimore); 2018 Mar; 97(9):e0053. PubMed ID: 29489662
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Lamivudine or Telbivudine in Preventing Mother-to-Child Transmission of Hepatitis B Virus: A Real-World Study.
Li Z; Duan X; Hu Y; Zhou M; Liu M; Kang K; Cai H; Yi W; Fu D; Gao X
Biomed Res Int; 2020; 2020():1374276. PubMed ID: 32420317
[TBL] [Abstract][Full Text] [Related]
8. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
9. Efficacy and Long-term Safety of Telbivudine Usage During Second or Third Trimester in Hepatitis B Surface Antigen Positive Mothers With High Viral Load: A 10-year Prospective Study.
Jiang H; Ye X; Chen C; Zhou G; Han G
J Clin Gastroenterol; 2023 Apr; 57(4):423-428. PubMed ID: 36227027
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China.
Sheng Q; Ding Y; Li B; Han C; Li Y; Zhang C; Bai H; Wang J; Zhao L; Xia T; An Z; Zhang M; Dou X
Int J Med Sci; 2018; 15(8):796-801. PubMed ID: 30008589
[No Abstract] [Full Text] [Related]
11. Efficacy and safety of tenofovir disoproxil fumarate or telbivudine used throughout pregnancy for the prevention of mother-to-child transmission of hepatitis B virus: A cohort study.
Li Z; Xie B; Yi N; Cai H; Yi W; Gao X
Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():102-106. PubMed ID: 35853269
[TBL] [Abstract][Full Text] [Related]
12. Developmental Consequences of Prenatal Telbivudine Exposure during the Third Trimester.
Pan CQ; Li MH; Zeng HH; Zhang Y; Cao WH; Wang Y; Zhou MF; Hu YH; Wan G; Xie Y; Yi W
Clin Gastroenterol Hepatol; 2021 May; 19(5):1061-1063. PubMed ID: 32371166
[TBL] [Abstract][Full Text] [Related]
13. [Maternal-fetal outcomes of lamivudine treatment administered during late pregnancy to highly viremic mothers with HBeAg+ chronic hepatitis B].
Jiang HX; Han GR; Wang CM; Ji Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):888-91. PubMed ID: 23522247
[TBL] [Abstract][Full Text] [Related]
14. The effect of maternal use of telbivudine on neonatal CD4
Liang X; Liu P; He Z; Chen X; Xiao X
Clin Res Hepatol Gastroenterol; 2020 Apr; 44(2):195-203. PubMed ID: 31257091
[TBL] [Abstract][Full Text] [Related]
15. Comparison of tenofovir disoproxil fumarate and telbivudine in preventing hepatitis B transmission in mothers with high viral load.
Wang M; Ran R; Zhu Y; Zhang H
Int J Gynaecol Obstet; 2023 Feb; 160(2):646-652. PubMed ID: 35816243
[TBL] [Abstract][Full Text] [Related]
16. Long-term safety and efficacy of telbivudine in infants born to mothers treated during the second or third trimesters of pregnancy.
Han GR; Jiang HX; Wang CM; Ding Y; Wang GJ; Yue X; Zhou L; Zhao W
J Viral Hepat; 2017 Jun; 24(6):514-521. PubMed ID: 28039902
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
Xu J; Tao LL; Ma LX
J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
[TBL] [Abstract][Full Text] [Related]
18. Comparison of telbivudine versus lamivudine in interrupting perinatal transmission of hepatitis B virus.
Yu MM; Jiang Q; Ji Y; Wu KH; Ju LL; Tang X; Yang YF
J Clin Virol; 2014 Sep; 61(1):55-60. PubMed ID: 24994007
[TBL] [Abstract][Full Text] [Related]
19. Telbivudine Treatment during Late Pregnancy Prevents Mother-to-Child Transmission of Hepatitis B Virus: A Retrospective Study.
Cai M; Hao Y; Zhong J; Yao W; Cao X; Gu G; Qin G
Can J Gastroenterol Hepatol; 2019; 2019():9046260. PubMed ID: 31380321
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
